1-9 of 9
Anderson Ryan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating free DNA as a surrogate for tumor material for EGFR and KRAS analysis

Gillian Ellison, James Sherwood, Carolyn Gokhale, Andrew Wallace, Robert Elles, Anderson Ryan
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (19_Supplement): PR4.
https://doi.org/10.1158/DIAG-10-PR4
Published: 15 August 2014
View articletitled, Circulating free DNA as a surrogate for tumor material for EGFR and KRAS analysis
Journal Articles

Combined MEK and VEGFR Inhibition in Orthotopic Human Lung Cancer Models Results in Enhanced Inhibition of Tumor Angiogenesis, Growth, and Metastasis

Osamu Takahashi, Ritsuko Komaki, Paul D. Smith, Juliane M. Jürgensmeier, Anderson Ryan, B. Nebiyou Bekele, Ignacio I. Wistuba, Jörg J. Jacoby, Maria V. Korshunova, Anna Biernacka, Baruch Erez, Keiko Hosho, Roy S. Herbst, Michael S. O'Reilly
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1641–1654.
https://doi.org/10.1158/1078-0432.CCR-11-2324
Published: 14 March 2012
View articletitled, Combined MEK and VEGFR Inhibition in Orthotopic Human Lung Cancer Models Results in Enhanced Inhibition of Tumor Angiogenesis, Growth, and Metastasis
Open the PDF for Combined MEK and VEGFR Inhibition in Orthotopic Human Lung Cancer Models Results in Enhanced Inhibition of Tumor Angiogenesis, Growth, and Metastasis in another window
Journal Articles

Vascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers

Neil R. Smith, Dawn Baker, Neil H. James, Kirsty Ratcliffe, Martin Jenkins, Susan E. Ashton, Graham Sproat, Ruth Swann, Neil Gray, Anderson Ryan, Juliane M. Jürgensmeier, Chris Womack
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (14): 3548–3561.
https://doi.org/10.1158/1078-0432.CCR-09-2797
Published: 14 July 2010
View articletitled, Vascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers
Open the PDF for Vascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers in another window
Includes: Supplementary data
Journal Articles

Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells

Roberto Bianco, Roberta Rosa, Vincenzo Damiano, Gennaro Daniele, Teresa Gelardi, Sonia Garofalo, Valeria Tarallo, Sandro De Falco, Davide Melisi, Roberto Benelli, Adriana Albini, Anderson Ryan, Fortunato Ciardiello, Giampaolo Tortora
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (16): 5069–5080.
https://doi.org/10.1158/1078-0432.CCR-07-4905
Published: 12 August 2008
View articletitled, Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells
Open the PDF for Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Antitumor Vascular Strategy for Controlling Experimental Metastatic Spread of Human Small-Cell Lung Cancer Cells with ZD6474 in Natural Killer Cell–Depleted Severe Combined Immunodeficient Mice

Seiji Yano, Hiroaki Muguruma, Yuka Matsumori, Hisatsugu Goto, Emiko Nakataki, Nobutaka Edakuni, Hideki Tomimoto, Soji Kakiuchi, Akihiko Yamamoto, Hisanori Uehara, Anderson Ryan, Saburo Sone
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (24): 8789–8798.
https://doi.org/10.1158/1078-0432.CCR-05-0674
Published: 16 December 2005
View articletitled, Antitumor Vascular Strategy for Controlling Experimental Metastatic Spread of Human Small-Cell Lung Cancer Cells with ZD6474 in Natural Killer Cell–Depleted Severe Combined Immunodeficient Mice
Open the PDF for Antitumor Vascular Strategy for Controlling Experimental Metastatic Spread of Human Small-Cell Lung Cancer Cells with ZD6474 in Natural Killer Cell–Depleted Severe Combined Immunodeficient Mice in another window
Journal Articles

Cooperative Antitumor Effect of Multitargeted Kinase Inhibitor ZD6474 and Ionizing Radiation in Glioblastoma

Vincenzo Damiano, Davide Melisi, Cataldo Bianco, David Raben, Rosa Caputo, Gabriella Fontanini, Roberto Bianco, Anderson Ryan, A. Raffaele Bianco, Sabino De Placido, Fortunato Ciardiello, Giampaolo Tortora
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (15): 5639–5644.
https://doi.org/10.1158/1078-0432.CCR-05-0174
Published: 01 August 2005
View articletitled, Cooperative Antitumor Effect of Multitargeted Kinase Inhibitor ZD6474 and Ionizing Radiation in Glioblastoma
Open the PDF for Cooperative Antitumor Effect of Multitargeted Kinase Inhibitor ZD6474 and Ionizing Radiation in Glioblastoma in another window
Journal Articles

Differential Effects of Vascular Endothelial Growth Factor Receptor-2 Inhibitor ZD6474 on Circulating Endothelial Progenitors and Mature Circulating Endothelial Cells: Implications for Use as a Surrogate Marker of Antiangiogenic Activity

Paul Beaudry, Jeremy Force, George N. Naumov, Andrew Wang, Cheryl H. Baker, Anderson Ryan, Shay Soker, Bruce E. Johnson, Judah Folkman, John V. Heymach
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (9): 3514–3522.
https://doi.org/10.1158/1078-0432.CCR-04-2271
Published: 02 May 2005
View articletitled, Differential Effects of Vascular Endothelial Growth Factor Receptor-2 Inhibitor ZD6474 on Circulating Endothelial Progenitors and Mature Circulating Endothelial Cells: Implications for Use as a Surrogate Marker of Antiangiogenic Activity
Open the PDF for Differential Effects of Vascular Endothelial Growth Factor Receptor-2 Inhibitor ZD6474 on Circulating Endothelial Progenitors and Mature Circulating Endothelial Cells: Implications for Use as a Surrogate Marker of Antiangiogenic Activity in another window
Journal Articles

Effect of the Tumor Vascular-Damaging Agent, ZD6126, on the Radioresponse of U87 Glioblastoma

Phyllis R. Wachsberger, Randy Burd, Nichol Marero, Constantine Daskalakis, Anderson Ryan, Peter McCue, Adam P. Dicker
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (2): 835–842.
https://doi.org/10.1158/1078-0432.835.11.2
Published: 08 February 2005
View articletitled, Effect of the Tumor Vascular-Damaging Agent, ZD6126, on the Radioresponse of U87 Glioblastoma
Open the PDF for Effect of the Tumor Vascular-Damaging Agent, ZD6126, on the Radioresponse of U87 Glioblastoma in another window
Journal Articles

Inhibition of Src Tyrosine Kinase as Treatment for Human Pancreatic Cancer Growing Orthotopically in Nude Mice

Maksim V. Yezhelyev, Gudrun Koehl, Markus Guba, Thomas Brabletz, Karl-Walter Jauch, Anderson Ryan, Alan Barge, Tim Green, Michael Fennell, Christiane J. Bruns
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (23): 8028–8036.
https://doi.org/10.1158/1078-0432.CCR-04-0621
Published: 07 December 2004
View articletitled, Inhibition of Src Tyrosine Kinase as Treatment for Human Pancreatic Cancer Growing Orthotopically in Nude Mice
Open the PDF for Inhibition of Src Tyrosine Kinase as Treatment for Human Pancreatic Cancer Growing Orthotopically in Nude Mice in another window